Specific activity of class II histone deacetylases in human breast cancer cells - Test2 - elhamkhani - TriplyDB

Specific activity of class II histone deacetylases in human breast cancer cells

Specific activity of class II histone deacetylases in human breast cancer cells

http://www.wikidata.org/entity/Q33606021

about

Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells Protein modifications as potential biomarkers in breast cancer.Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.Histone deacetylases and cancer.Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?Augmenting antitumor immune responses with epigenetic modifying agents.An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression Histone/protein deacetylases and T-cell immune responses Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer.Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.Pharmacotherapy of triple-negative breast cancer.Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.Small-molecule chromatin-modifying agents: therapeutic applications.Possible role of autophagy in the treatment of pancreatic cancer with histone deacetylase inhibitors.Selective class IIa HDAC inhibitors: myth or reality.Histone deacetylase inhibitors in oral squamous cell carcinoma treatment.Chromatin remodeler mutations in human cancers: epigenetic implications.Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas The role of REST and HDAC2 in epigenetic dysregulation of Nav1.5 and nNav1.5 expression in breast cancer.MC1568 inhibits HDAC6/8 activity and influenza A virus replication in lung epithelial cells: role of Hsp90 acetylation.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.Identifying targets for the restoration and reactivation of BRM.Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells.Diallyl disulfide-induced apoptosis in a breast-cancer cell line (MCF-7) may be caused by inhibition of histone deacetylation.Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation.Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells.Prior alcohol use enhances vulnerability to compulsive cocaine self-administration by promoting degradation of HDAC4 and HDAC5.HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity.

P2860

Q28475537-4B1BF99A-AC19-4498-B38F-F01D956709FC Q28478183-B1355D44-393A-4647-954D-8C0280E20454 Q33586407-F0E30779-21CA-4E9C-AFD3-23A100D479CA Q33626512-DF5DE064-E149-406C-9E23-25D5763AE7F5 Q34150018-F92828E4-99E8-45AB-A616-C433B995D5E7 Q34298745-B60CC92B-7AAC-4016-BAA5-1D9876C6C8FA Q34318452-385E15AD-C1D2-4584-9928-12C5DF14B933 Q34417159-E45EAED2-7EB8-48AB-A00E-E33F3181112D Q35048054-8769E34D-5880-4C1F-BC61-48BEFD7FBCD4 Q35085026-696F0B49-D54A-4DB6-BDB3-D76CFAB52BFF Q35201384-CD5CBBA0-B353-46D2-BE1C-1BC59FA94D9F Q35849307-28E06EA9-0B6B-4D93-B1FD-75F55FDE1DC3 Q36145714-C652A6F9-1795-450A-B948-F2C3631026E5 Q37062452-373BFE6E-AACC-48AF-8C02-6266EB2931E6 Q37092688-7FCA7EE3-26D9-48C7-A865-8E4556431BB8 Q37190152-3F11E110-E07A-4AB3-930E-EC8ACF1B3D3A Q37190330-D7ECFF20-3165-4F69-BDCB-2B7A7BCA101E Q37417983-0AA6A9FD-1D19-4599-B7CF-6E47436BECB2 Q37565645-BC4BCE21-1B68-4E19-877A-9578673FA394 Q37568629-C250A239-22B5-4141-8D58-0C3DC16E588D Q37961728-0EF4FC4F-CF26-4789-8BDC-09AAD016384A Q38166587-3B18E909-3210-4177-BA99-DC7530D14A89 Q38246144-8735A747-E9C3-496C-B04D-21481E2C4D8F Q38248710-22993648-2194-41EA-8C99-40784CC9E42D Q38261746-73398B56-842E-4E6F-8B02-F386CB512D0A Q38663683-D7AEA6AB-C3C5-475B-91FC-8FFEBB8153F1 Q38695555-311BC7CE-23F5-42B4-A7C6-8C31546B48A9 Q38811813-2E5A5E98-8C85-45A8-BA71-C5EE34EECF20 Q38947405-DC6A0459-2AEF-446A-AEC4-8624341462D5 Q39038132-F939094F-781D-43BE-A636-22502ED92F40 Q39176128-2086756A-D19E-4A4A-88C6-95F59E324D3B Q39176522-CA2CC319-2FB2-4813-A59E-83823D92E090 Q39240051-D4D05854-A76D-42B3-8C14-A5424C70E7A9 Q39242576-55922EC6-DAE7-47BB-8FB0-2348DDF6AF19 Q39738064-1C67173D-0CF6-4641-946B-389771A7580A Q39791600-EF83978F-D3F6-4D78-A646-A18430DA7D6F Q43537686-2A42D9A5-4893-4B7A-8842-AD16567DD481 Q45902136-98491D08-D774-4840-92FF-37F63D0C12C9 Q47114002-85497B4F-E14F-48BE-9A2E-01710559BE0C Q47610009-7F440681-9C1B-4A4E-9197-66886ADEFC9C

P2860

Specific activity of class II histone deacetylases in human breast cancer cells

http://www.wikidata.org/entity/Q33606021

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Specific activity of class II histone deacetylases in human breast cancer cells

@ast

Specific activity of class II histone deacetylases in human breast cancer cells

@en

type

label

Specific activity of class II histone deacetylases in human breast cancer cells

@ast

Specific activity of class II histone deacetylases in human breast cancer cells

@en

prefLabel

Specific activity of class II histone deacetylases in human breast cancer cells

@ast

Specific activity of class II histone deacetylases in human breast cancer cells

@en

P1433

Q33606021-BA018164-0D58-4324-9AE1-950E29905871

P1476

Q33606021-18D133D2-C595-40B6-8639-C1C076605AE4

P2093

Q33606021-169D3F66-4914-4E31-8F28-D0A9DE0786D5

Q33606021-20876CA3-D8ED-4436-993C-D4D0893D1FE2

Q33606021-2FFE9B9F-BF8E-42E5-98A6-795E5F23DD06

Q33606021-54CB89D8-3383-41E3-93C8-1FAD14A3BAD5

Q33606021-55F34EBE-B0B4-4690-82BC-DDFC7E74B5BC

Q33606021-633D8C97-3327-4970-869B-6B4121DBBA23

Q33606021-897398EB-69F4-4264-975C-D68A0D91C82D

Q33606021-A1E61785-F9D1-4FEA-9B7F-6FA04CF002BA

Q33606021-A4844E6D-CE4E-4166-B7A8-00C09CABE589

P2860

Q33606021-012BC7B3-3780-43E6-ABC0-0A1F237CB1C9

Q33606021-091E5022-1C99-4A7D-87EE-DD5DE6CFEE50

Q33606021-0AECEE4F-A65B-4D9E-B191-ADFEF64E74F7

Q33606021-0C54AFE1-812E-461A-9046-8375E95019D7

Q33606021-1197139B-2EEA-48B6-AEBF-6950AFCF79AD

Q33606021-13E2DB0B-A955-45F8-ABB7-FF908C78E686

Q33606021-20AA1D43-4F3B-4108-95DE-F3B3B63B0CA1

Q33606021-2CB743E1-F25E-4417-93CE-D9EBCB74461F

Q33606021-2F25789A-7923-4376-8055-6DAAF51BF16B

Q33606021-3AB30820-1A0E-44FE-BA0F-4FF21010548F

P304

Q33606021-CE192C4D-E986-4444-B31E-B09CF407511F

P31

Q33606021-17D369BA-DEF5-4996-9637-8A9C6130298E

P356

Q33606021-D7D4F2C0-36AD-4693-94E7-8C6428EEF995

P433

Q33606021-E3D2CFBC-A585-4162-AD11-E874FDFC24E9

P478

Q33606021-E1CFBAD6-152F-4B89-BCD4-DFF67D157A15

P50

Q33606021-4399ABFD-B291-4F8E-90EE-3A4F811FCBF6

Q33606021-827E83C1-E0EF-4D0A-B932-81C0FD380672

Q33606021-FDA471DC-89BE-437C-A737-96CEB1AD0F90

P577

Q33606021-4D0CEF20-F695-4218-B29A-14F96F77EF4D

P5875

Q33606021-DB6BDD3A-DDB8-4728-8F7C-00D7C3886060

P698

Q33606021-515E833F-A3C8-40D7-B755-81793DFF9F97

P932

Q33606021-A3194868-6A55-4313-B50A-141FD38CB503

P356

1541-7786.MCR-08-0299

P1433

Molecular Cancer Research

P1476

Specific activity of class II histone deacetylases in human breast cancer cells

@en

P2093

Caroline Bret

http://www.w3.org/2001/XMLSchema#string

Céline Duraffourd

http://www.w3.org/2001/XMLSchema#string

Julie Loubersac

http://www.w3.org/2001/XMLSchema#string

Nathalie Boulle

http://www.w3.org/2001/XMLSchema#string

Pierre-Olivier Harmand

http://www.w3.org/2001/XMLSchema#string

Sandrine Bonnet

http://www.w3.org/2001/XMLSchema#string

Thierry Maudelonde

http://www.w3.org/2001/XMLSchema#string

Vanessa Duong

http://www.w3.org/2001/XMLSchema#string

Vincent Cavailles

http://www.w3.org/2001/XMLSchema#string

P2860

HDAC6 is a microtubule-associated deacetylase

HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates

Nuclear hormone receptors and gene expression

HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis

HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention

Reporter cell lines to study the estrogenic effects of xenoestrogens

Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis

Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Anticancer activities of histone deacetylase inhibitors

P304

1908-1919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-08-0299

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23655733

http://www.w3.org/2001/XMLSchema#string

P698

19074835

http://www.w3.org/2001/XMLSchema#string

P932

2810315

http://www.w3.org/2001/XMLSchema#string